Methotrexate
- Product NDC
- 62135-772
- 11-digit product format
- 621350772
- Labeler code
- 62135
- Product ID
- 62135-772_462a5023-e5a1-692a-e063-6294a90a7236
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA210454
- Marketing category
- ANDA
- Marketing start
- 2020-01-30
- Substance
- METHOTREXATE SODIUM
- Active strength
- 2.5 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Methotrexate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| METHOTREXATE SODIUM | 2.5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 3IG1E710ZN |
| Rxcui | 105585 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 62135-772-35 | Methotrexate | 36 in 1 BOTTLE | TABLET | 36 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 62135-772 | METHOTREXATE TABLET [CHARTWELL RX, LLC] | 2 | Current NDC, 1 package rows | 20241025_2609da8f-80dc-448e-8eba-35d11488ce7f.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-772-35 | 62135077235 | 36 TABLET in 1 BOTTLE (62135-772-35) | 36 tablet | 2023-08-29 | No | No | Current |